← Back to Search

Analgesic

Intervention group for Acute Pain

Phase 4
Waitlist Available
Led By Sandra Cunningham, MD
Research Sponsored by New York City Health and Hospitals Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with a numeric pain score of greater than or equal to 5 or Wong -Baker FACES Pain Scale of greater than or equal to 6
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour and 2 hours
Awards & highlights

Study Summary

This study is evaluating whether a combination of ibuprofen and acetaminophen may be more effective than ibuprofen alone for the treatment of pain in children.

Eligible Conditions
  • Acute Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour and 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour and 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain score
Secondary outcome measures
Number of participants requiring rescue medications.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Intervention groupActive Control2 Interventions
Intervention Group: ibuprofen 10 mg/kg (maximum 600mg) plus acetaminophen 15mg/kg (maximum 650mg)
Group II: Placebo GroupPlacebo Group2 Interventions
Placebo Group: Ibuprofen 10mg/kg (maximum 600 mg) plus placebo 15mg/kg (maximum 650mg)

Find a Location

Who is running the clinical trial?

New York City Health and Hospitals CorporationLead Sponsor
32 Previous Clinical Trials
8,373 Total Patients Enrolled
Sandra Cunningham, MDPrincipal InvestigatorNYCHHC - Jacobi Medical Center
1 Previous Clinical Trials
82 Total Patients Enrolled

Frequently Asked Questions

~25 spots leftby Apr 2025